Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 30, Number 8—August 2024
Research Letter
Emayella augustorita, New Member of Pasteurellaceae, Isolated from Blood Cultures of Septic Patient
Table
MIC values observed for LIM206, Emayella augustorita, a novel bacteria of the Pasteurellaceae family recovered from a patient with sepsis, France*
Antibiotic | PK/PD breakpoints, mg/L† | MIC, mg/L |
---|---|---|
Amoxicillin | 2–8 | 0.75 |
Amoxicillin + clavulanic acid | 2–8 | 0.75 |
Piperacillin + tazobactam | 8–16 | 1.0 |
Cefotaxime | 1–2 | 0.032 |
Levofloxacin | 0.5–1 | 0.064 |
Trimethoprim/sulfamethoxazole | 0.5 | 0.004 |
*PK/PD, pharmacokinetics/pharmacodynamics. †All breakpoints were from EUCAST except for trimethoprim/sulfamethoxazole, which was epidemiologic cutoff value.
Page created: May 24, 2024
Page updated: June 20, 2024
Page reviewed: June 20, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.